Trial Profile
A retrospective study of rifaximin in cirrhotic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- 27 Feb 2016 New trial record